XML 33 R21.htm IDEA: XBRL DOCUMENT v3.25.3

Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2025

Revenue Recognition [Abstract]

Schedule of Disaggregated Revenue

Net Sales by Business
	Three Months				Nine Months
	2025		2024		2025		2024
MedSurg and Neurotechnology:
Instruments	$760		$679		$2,258		$2,044
Endoscopy	896		837		2,662		2,383
Medical	985		938		2,920		2,710
Vascular	525		329		1,429		966
Neuro Cranial	637		541		1,816		1,533
	$3,803		$3,324		$11,085		$9,636
Orthopaedics:
Knees	$628		$570		$1,907		$1,760
Hips	457		420		1,366		1,241
Trauma and Extremities	960		849		2,862		2,511
Spinal Implants	6		172		177		521
Other	203		159		548		490
	$2,254		$2,170		$6,860		$6,523
Total	$6,057		$5,494		$17,945		$16,159

Net Sales by Geography
	Three Months 2025			Three Months 2024
	United States	International		United States	International
MedSurg and Neurotechnology:
Instruments	$606	$154		$544	$135
Endoscopy	743	153		689	148
Medical	827	158		783	155
Vascular	283	242		121	208
Neuro Cranial	524	113		448	93
	$2,983	$820		$2,585	$739
Orthopaedics:
Knees	$452	$176		$417	$153
Hips	279	178		256	164
Trauma and Extremities	703	257		621	228
Spinal Implants	—	6		119	53
Other	154	49		111	48
	$1,588	$666		$1,524	$646
Total	$4,571	$1,486		$4,109	$1,385

Net Sales by Geography
	Nine Months 2025			Nine Months 2024
	United States	International		United States	International
MedSurg and Neurotechnology:
Instruments	$1,814	$444		$1,640	$404
Endoscopy	2,195	467		1,948	435
Medical	2,469	451		2,261	449
Vascular	754	675		369	597
Neuro Cranial	1,496	320		1,255	278
	$8,728	$2,357		$7,473	$2,163
Orthopaedics:
Knees	$1,376	$531		$1,279	$481
Hips	831	535		768	473
Trauma and Extremities	2,118	744		1,842	669
Spinal Implants	118	59		361	160
Other	394	154		347	143
	$4,837	$2,023		$4,597	$1,926
Total	$13,565	$4,380		$12,070	$4,089

Contract with Customer, Contract Asset, Contract Liability, and Receivable

Changes in contract liabilities during the nine months 2025 were

as follows:

	September 30
	2025
Beginning contract liabilities	$978
Revenue recognized from beginning of year contract liabilities	(492)
Net advance consideration received during the period	453
Ending contract liabilities	$939

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueRecognitionAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration